112 related articles for article (PubMed ID: 25256553)
1. Thrombospondin-1 is part of a Slug-independent motility and metastatic program in cutaneous melanoma, in association with VEGFR-1 and FGF-2.
Borsotti P; Ghilardi C; Ostano P; Silini A; Dossi R; Pinessi D; Foglieni C; Scatolini M; Lacal PM; Ferrari R; Moscatelli D; Sangalli F; D'Atri S; Giavazzi R; Bani MR; Chiorino G; Taraboletti G
Pigment Cell Melanoma Res; 2015 Jan; 28(1):73-81. PubMed ID: 25256553
[TBL] [Abstract][Full Text] [Related]
2. Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.
Straume O; Akslen LA
Am J Pathol; 2001 Jul; 159(1):223-35. PubMed ID: 11438469
[TBL] [Abstract][Full Text] [Related]
3. The role of vascular endothelial growth factors and their receptors in malignant melanomas.
Brychtova S; Bezdekova M; Brychta T; Tichy M
Neoplasma; 2008; 55(4):273-9. PubMed ID: 18505336
[TBL] [Abstract][Full Text] [Related]
4. Slug expression during melanoma progression.
Shirley SH; Greene VR; Duncan LM; Torres Cabala CA; Grimm EA; Kusewitt DF
Am J Pathol; 2012 Jun; 180(6):2479-89. PubMed ID: 22503751
[TBL] [Abstract][Full Text] [Related]
5. The melanocyte differentiation program predisposes to metastasis after neoplastic transformation.
Gupta PB; Kuperwasser C; Brunet JP; Ramaswamy S; Kuo WL; Gray JW; Naber SP; Weinberg RA
Nat Genet; 2005 Oct; 37(10):1047-54. PubMed ID: 16142232
[TBL] [Abstract][Full Text] [Related]
6. Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.
Crende O; Sabatino M; Valcárcel M; Carrascal T; Riestra P; López-Guerrero JA; Nagore E; Mandruzzato S; Wang E; Marincola FM; Vidal-Vanaclocha F
Am J Pathol; 2013 Jul; 183(1):69-82. PubMed ID: 23707237
[TBL] [Abstract][Full Text] [Related]
7. Interference of macrophage migration inhibitory factor expression in a mouse melanoma inhibits tumor establishment by up-regulating thrombospondin-1.
Culp WD; Tsagozis P; Burgio M; Russell P; Pisa P; Garland D
Mol Cancer Res; 2007 Dec; 5(12):1225-31. PubMed ID: 18171979
[TBL] [Abstract][Full Text] [Related]
8. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G
Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214
[TBL] [Abstract][Full Text] [Related]
9. Thrombospondin 1 as a scavenger for matrix-associated fibroblast growth factor 2.
Margosio B; Marchetti D; Vergani V; Giavazzi R; Rusnati M; Presta M; Taraboletti G
Blood; 2003 Dec; 102(13):4399-406. PubMed ID: 12947001
[TBL] [Abstract][Full Text] [Related]
10. Matricellular TSP-1 as a target of interest for impeding melanoma spreading: towards a therapeutic use for TAX2 peptide.
Jeanne A; Boulagnon-Rombi C; Devy J; Théret L; Fichel C; Bouland N; Diebold MD; Martiny L; Schneider C; Dedieu S
Clin Exp Metastasis; 2016 Oct; 33(7):637-49. PubMed ID: 27349907
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor 8 induced downregulation of thrombospondin 1 is mediated by the MEK/ERK and PI3K pathways in breast cancer cells.
Tarkkonen K; Ruohola J; Härkönen P
Growth Factors; 2010 Aug; 28(4):256-67. PubMed ID: 20370578
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor-2 modulates melanoma adhesion and migration through a syndecan-4-dependent mechanism.
Chalkiadaki G; Nikitovic D; Berdiaki A; Sifaki M; Krasagakis K; Katonis P; Karamanos NK; Tzanakakis GN
Int J Biochem Cell Biol; 2009 Jun; 41(6):1323-31. PubMed ID: 19110070
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor-2 transiently activates the p53 oncosuppressor protein in human primary vascular smooth muscle cells: implications for atherogenesis.
Barillari G; Iovane A; Bonuglia M; Albonici L; Garofano P; Di Campli E; Falchi M; Condò I; Manzari V; Ensoli B
Atherosclerosis; 2010 Jun; 210(2):400-6. PubMed ID: 20122687
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of VEGF-receptors (FLT-1, KDR, NRP-1) and thrombospondin-1 is associated with glomeruloid microvascular proliferation, an aggressive angiogenic phenotype, in malignant melanoma.
Straume O; Akslen LA
Angiogenesis; 2003; 6(4):295-301. PubMed ID: 15166498
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of melanocytic tissue array reveals inverse correlation between activator protein-2alpha and protease-activated receptor-1 expression during melanoma progression.
Tellez CS; Davis DW; Prieto VG; Gershenwald JE; Johnson MM; McCarty MF; Bar-Eli M
J Invest Dermatol; 2007 Feb; 127(2):387-93. PubMed ID: 16946713
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
[TBL] [Abstract][Full Text] [Related]
17. Expression of the soluble vascular endothelial growth factor receptor-1 in cutaneous melanoma: role in tumour progression.
Ruffini F; Failla CM; Orecchia A; Bani MR; Dorio AS; Fortes C; Zambruno G; Graziani G; Giavazzi R; D'Atri S; Lacal PM
Br J Dermatol; 2011 May; 164(5):1061-70. PubMed ID: 21198538
[TBL] [Abstract][Full Text] [Related]
18. A novel role for microphthalmia-associated transcription factor-regulated pigment epithelium-derived factor during melanoma progression.
Dadras SS; Lin RJ; Razavi G; Kawakami A; Du J; Feige E; Milner DA; Loda MF; Granter SR; Detmar M; Widlund HR; Horstmann MA; Fisher DE
Am J Pathol; 2015 Jan; 185(1):252-65. PubMed ID: 25447045
[TBL] [Abstract][Full Text] [Related]
19. Exogenous fibroblast growth factor-2 induces a transformed phenotype in vascular kaposi's sarcoma-like cells.
Cavallaro U; Soria MR; Montesano R
Mol Cell Biol Res Commun; 2000 Oct; 4(4):203-5. PubMed ID: 11409912
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor signaling pathway in endothelial cells is activated by BMPER to promote angiogenesis.
Esser JS; Rahner S; Deckler M; Bode C; Patterson C; Moser M
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):358-67. PubMed ID: 25503991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
